Log in to save to my catalogue

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-M...

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-M...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2928244984

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. Treatment typically includes symptomatic oral cholinesterase inhibitors, immunosuppression, and immunomodulation. In addition to corticosteroids, azathioprine and mycophenolate mofetil are the most frequently used immunosuppressants in North America. We aimed to evaluate the...

Alternative Titles

Full title

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2928244984

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2928244984

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(24)00028-0

How to access this item